We next tested the prediction ability of IFN-γ/IMS in a newly generated RNA-seq dataset from 55 tumor tissues of melanoma patients treated with anti-PD-1 monotherapy at Peking University Cancer Hospital (PUCH), Beijing, China. The gene discussed is IFNG; the disease is melanoma.